-
Ko 143 in BCRP Transporter Assays
2026-09-18
Learn how Ko 143, SKU A3533, can help distinguish BCRP-mediated drug efflux from nonspecific assay variability in viability, cytotoxicity, and pharmacokinetic studies. This scenario-based guide covers experimental design, solvent compatibility, protocol optimization, data interpretation, and practical product selection.
-
Fad2, Acsl4, and Rice Blast Pathogenicity
2026-09-18
A 2024 study links Fad2- and Acsl4-dependent polyunsaturated phospholipid biosynthesis with ferroptosis-associated development and pathogenicity in Magnaporthe oryzae. Mutant phenotyping, targeted lipidomics, oxidative perturbation, and redox-interaction analysis together identify PUFA-containing phospholipids as a mechanistic connection between fungal cell death and rice blast infection.
-
Angiotensin 1/2 (5-7) in RAS Research
2026-09-17
Angiotensin 1/2 (5-7) enables controlled studies of short angiotensin-fragment activity in cardiovascular assays and spike–receptor binding models. This workflow guide covers solution preparation, comparative controls, assay design, and troubleshooting for reproducible renin-angiotensin system research.
-
Oxaliplatin Workflows for DNA-Damage Research
2026-09-17
Build more reproducible Oxaliplatin assays by connecting fresh-solution handling, exposure timing, apoptosis readouts, and resistance biology. The workflow translates evidence from hepatocellular carcinoma models into practical combination, sequencing, and troubleshooting strategies for cancer chemotherapy research.
-
Repaglinide as a Metabolic Control in DNA-Repair Studies
2026-09-16
Repaglinide is best understood as a beta-cell stimulus-secretion probe, not an AML therapy. This article explains how its pharmacology can sharpen experimental controls around energy stress, ATG4B nuclear translocation, PRMT1-MRE11 signaling, and DNA-repair interpretation.
-
Diuron Research Workflows for Plant and Kidney Toxicology
2026-09-16
Diuron supports a two-track research strategy: controlled photosynthesis inhibition in plant biology research and mechanistic toxicology in renal cell models. This workflow translates its solvent, storage, and assay characteristics into reproducible screening, pathway validation, and troubleshooting decisions.
-
EphA2 Synthetic Lethality in MYC-Driven TNBC
2026-09-15
A chemogenetic kinase-inhibitor screen identified EphA2 as a synthetic lethal vulnerability in MYC-driven triple-negative breast cancer. The study links the EphA2 inhibitor ALW-II-41-27 to MYC-selective intrinsic apoptosis, activity across p53 contexts, and tumor-growth suppression in TNBC xenografts, while also defining important limitations for translational interpretation.
-
Metal-Chelating l-Phe Nanostructures Improve ICB
2026-09-15
This Nature Nanotechnology study shows that metal-ion-chelating l-phenylalanine nanostructures can activate dendritic cells by changing potassium and calcium signaling, while short-term starvation improves nanostructure uptake and antitumor immunity. The findings provide a mechanistic strategy for remodeling immunosuppressive tumor microenvironments and increasing sensitivity to immune checkpoint blockade.
-
Naftifine HCl Workflows for Antifungal Research
2026-09-14
Build reproducible sterol-biosynthesis and fungal membrane assays with Naftifine HCl, using solvent-aware dosing, matched controls, and orthogonal readouts. The workflow also translates a muscle-regeneration study into a practical lesson: distinguish pathway-specific effects from generalized cell injury.
-
DOPE: Designing LNPs for Translational RNA Delivery
2026-09-14
A mechanistic and strategic guide to using 1,2-Dioleoyl-sn-glycero-3-PE (DOPE) as a helper phospholipid for nucleic acid delivery, with practical validation priorities and stability lessons from recent mRNA-LNP research.
-
DOPE Workflows for Lipid and Fungal Cell Assays
2026-09-13
1,2-Dioleoyl-sn-glycero-3-PE (DOPE) is more than a helper lipid for nucleic acid delivery: it can also serve as a controlled phosphatidylethanolamine input in mechanistic studies of fungal lipid peroxidation. This guide connects formulation practice, conidial assays, rescue experiments, and troubleshooting without treating a biological rescue result as proof of a finished delivery system.
-
Novobiocin Sodium: Practical Research Workflows
2026-09-12
Novobiocin Sodium provides a time-resolved way to connect DNA replication with bacterial growth, membrane synthesis, and vacuole formation. This workflow-focused guide covers stock preparation, qPCR and microscopy readouts, recovery experiments, and troubleshooting for antibiotic resistance and pathway research.
-
Cyclo (-RGDfC) for Reliable Integrin Assays
2026-09-11
This scenario-based guide shows how Cyclo (-RGDfC) (SKU A8790) can help researchers separate αvβ3-mediated adhesion effects from true changes in cell viability. It covers solvent compatibility, assay controls, interpretation of cytotoxicity data, and practical product-selection criteria.
-
Fluorouracil: An Evolution-Aware Assay Strategy
2026-09-11
Fluorouracil and 5-Fluorouracil can reveal more than a single cytotoxicity value. This guide connects thymidylate synthase inhibition with tumor evolution, model selection, time-resolved endpoints, and heterogeneity-aware assay design.
-
PF-562271 HCl: Linking FAK Signaling to CAMLs
2026-09-10
PF-562271 HCl is a selective FAK/Pyk2 inhibitor for dissecting adhesion, migration, and tumor signaling. This article connects its experimentally useful pharmacology with circulating polyploid giant cancer macrophages, while defining what is established, what remains hypothetical, and how to design informative assays.